Investigating the Promise of Anellovectors to Address Tropism, Immunogenicity & Redosing in Gene Therapy

Time: 5:45 pm
day: Day One

Details:

  • Sequencing of human anelloviruses reveals a vast genetic diversity with potential implications for gene therapy, such as:
    • Generating more targeted gene delivery vectors
    • Enabling re-dosing and improving the therapeutic index of gene therapies
  • An update will be provided on Ring Therapeutics’ efforts in developing Anellovectors

Speakers: